To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved ...

And other biotech news brought to you by The Readout.

And more pharma news updates from Pharmalittle.

Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...